Viatris Innovation GmbH clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   OPUS-2 · Research Study to Evaluate the Efficacy and Safety of…OPUS-2 · Research Study to Evaluate the Efficacy and Safety of Cenerimod · Systemic Lupus Erythematosus

   Primary completion pushed from Oct 31, 2026 to Dec 31, 2026

   Also in this update: Completion pushed from May 1, 2027 to Jun 30, 2027

   Viatris Innovation GmbH·Phase 3· NCT05672576· Registry history of NCT05672576 on ClinicalTrials.gov (opens the registry)

   Updated Sep 15, 2026

2. Minor

   OPUS-1 · Research Study to Evaluate the Effects of a New Oral…OPUS-1 · Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod · Systemic Lupus Erythematosus

   Primary completion pushed from Oct 31, 2026 to Mar 31, 2027

   Also in this update: Completion pushed from May 1, 2027 to Sep 30, 2027

   Viatris Innovation GmbH·Phase 3· NCT05648500· Registry history of NCT05648500 on ClinicalTrials.gov (opens the registry)

   Updated Sep 15, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.